D.A. Davidson & Co.

SEC CIK: 0001080107
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q2 2026): 87,741
Value: $2.26M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of DNLI by D.A. Davidson & Co., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	87,741	$2.26M	<0.1%	−22,494−20.4%	Reduced	Holders
Q1 2026	110,235	$2.12M	<0.1%	+3,302+3.1%	Added	Holders
Q4 2025	106,933	$1.77M	<0.1%	+106,933	New	Holders